The Harms of Psychedelics Have to Be Put Into Context
In November 2021, when the psychedelics firm Compass Pathways launched the top-line outcomes of its trial taking a look at psilocybin in sufferers with treatment-resistant despair, the inventory of the corporate plunged nearly 30 %. The…